Taspoglutidum
Taspoglutidum Uses, Dosage, Side Effects, Food Interaction and all others data.
Taspoglutidum is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche. In September 2010 Roche halted Phase III clinical trials due to incidences of serious hypersensitivity reactions and gastrointestinal side effects. As of May 2013 no new trials had been registered.
| Trade Name | Taspoglutidum |
| Generic | Taspoglutide |
| Taspoglutide Other Names | Taspoglutida, Taspoglutide, Taspoglutidum |
| Type | |
| Formula | C152H232N40O45 |
| Weight | Average: 3339.763 Monoisotopic: 3337.70952553 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Taspoglutidum
